Exercise Prescription Dose for Castration Resistance Prostate Cancer

Status Completed

Clinical Trial Summary

Recent drug improvement (e.g. abiraterone or enzalutamide) for castration resistant prostate cancer (CRPC) patients has improved survival. As treatment strategies improve and patients live longer, patients must cope with their treatment-induced adverse effects. Improving levels of physical activity (PA) and less amounts of sitting time (e.g. sedentary behavior, SB) could have a positive impact on patient's health, non-cancer mortality, and quality of life and potentially improve survival. The role of PA has not yet been examined in CRPC patients, which is a clear unmet need. No specific PA guidelines exist for CRPC patients, but specific guidelines are warranted because of advanced disease stage, reduced performance score and comorbidity. It is to be expected that the PA level of CRPC patients is lower compared to non-CRPC patients receiving androgen deprivation therapy (ADT). This study aims to determine the optimal starting physical therapy prescription in CRPC patients receiving second line hormone treatment.

Clinical Trial Description

CRPC patients receiving second-line hormone treatment at Ghent University Hospital are invited to participate in this phase I 3+3 dose escalation design (escalation to next exercise dose per 3 study patients). The prescription start dose is 15min. aerobic training (50-80% maximum heart rate (HRmax). warm-up and cooling-down and 65-80%HRmax. core), 1 set with 8-10 reps. resistance training (50-60% one repetition maximum (1RM), 8 exercises) and 1 set (30s.) with 2 reps. flexibility training (5 exercises). Factors determining compliance for the dose are tolerance and safety. Tolerance for the exercise prescription will be assessed with the Borg scale of perceived exertion after every exercise. Compliant for tolerance is a score ≤16. Safety will be assessed by the visual analogue scale (VAS) (assessed by the patient) for pain and the CTCAE criteria (assessed by a trained health care provider) for bone pain after every exercise. Compliant for safety is ≤3 VAS for exercise-induced pain and <grade 2 according to the CTCAE criteria. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03526562
Study type	Interventional
Source	University Hospital, Ghent
Contact
Status	Completed
Phase	N/A
Start date	January 15, 2018
Completion date	June 15, 2018

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05661799` - Persistence of Physical Activity in People With Type 2 Diabetes Over Time.	N/A
Active, not recruiting	`NCT03903874` - Testing Scalable, IVR-supported Cancer Prevention Interventions in the Rural Alabama Black Belt	N/A
Recruiting	`NCT03662438` - HOPE (Home-based Oxygen [Portable] and Exercise) for Patients on Long Term Oxygen Therapy (LTOT)	N/A
Withdrawn	`NCT04540523` - Home-Based Exergaming Intervention	N/A
Recruiting	`NCT03250000` - Changes in Microcirculation and Functional Status During Exacerbation of COPD	N/A
Recruiting	`NCT05563805` - Exploring Virtual Reality Adventure Training Exergaming	N/A
Completed	`NCT03430648` - Is Tau Protein Linked to Mobility Function?
Completed	`NCT05019482` - Intervention Program Among University Student to Promote Physical Activity and Reduce the Sedentary Time	N/A
Completed	`NCT03253406` - Health Wearables and College Student Health	N/A
Not yet recruiting	`NCT05985460` - A Very Brief Intervention to Increase the Intention to Practice Physical Activity	N/A
Completed	`NCT03380143` - Whole-of-Community Youth Population Physical Activity	N/A
Completed	`NCT03700736` - The Healthy Moms Study: Comparison of a Post-Partum Weight Loss Intervention Delivered Via Facebook or In-Person Groups	N/A
Completed	`NCT03170921` - Psychophysiological Characterization of Different Capoeira Performances in Experienced Individuals	N/A
Completed	`NCT04973813` - Active Choice Intervention About Physical Activity for Physically Inactive Adults	N/A
Completed	`NCT03982095` - Survey on Lifestyle, Perceived Barriers and Development of Change in Patients With Prostate Cancer
Completed	`NCT03271112` - Frailty Prevention in Elders From Reunion Island	N/A
Completed	`NCT05670223` - Healthy Activities Improve Lives	N/A
Completed	`NCT04894929` - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement	N/A
Recruiting	`NCT04578067` - Empowering Immigrant Women for Active and Healthy Lifestyle	N/A
Completed	`NCT03297567` - Physical Therapy Guidelines For Hospitalized Elderly	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Exercise Prescription Dose for Castration Resistance Prostate Cancer Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms